Amicus Therapeutics Balans Gezondheid
Financiële gezondheid criteriumcontroles 2/6
Amicus Therapeutics has a total shareholder equity of $123.0M and total debt of $392.0M, which brings its debt-to-equity ratio to 318.6%. Its total assets and total liabilities are $724.2M and $601.1M respectively.
Belangrijke informatie
318.6%
Verhouding schuld/eigen vermogen
US$391.99m
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$293.60m |
| Aandelen | US$123.05m |
| Totaal verplichtingen | US$601.12m |
| Totaal activa | US$724.17m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: FOLD *'s short term assets ($423.8M) exceed its short term liabilities ($139.0M).
Langlopende schulden: FOLD *'s short term assets ($423.8M) do not cover its long term liabilities ($462.1M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: FOLD *'s net debt to equity ratio (80%) is considered high.
Schuld verminderen: FOLD *'s debt to equity ratio has increased from 46.5% to 318.6% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: FOLD * has sufficient cash runway for more than a year based on its current free cash flow.
Voorspelling contante baan: Insufficient data to determine if FOLD * has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.